These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 16139885
1. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats. Przegaliński E, Filip M, Frankowska M, Zaniewska M, Papla I. Neuropeptides; 2005 Oct; 39(5):525-33. PubMed ID: 16139885 [Abstract] [Full Text] [Related]
2. Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. Goeders NE, Clampitt DM. Psychopharmacology (Berl); 2002 May; 161(3):222-32. PubMed ID: 12021825 [Abstract] [Full Text] [Related]
3. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats. Przegaliński E, Papla I, Siwanowicz J, Filip M. Eur Neuropsychopharmacol; 2004 May; 14(3):217-25. PubMed ID: 15056481 [Abstract] [Full Text] [Related]
4. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ. J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236 [Abstract] [Full Text] [Related]
5. Effects of serotonin (5-HT)(1B) receptor ligands, microinjected into accumbens subregions, on cocaine discrimination in rats. Filip M, Papla I, Nowak E, Jungersmith K, Przegaliński E. Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):226-34. PubMed ID: 12172705 [Abstract] [Full Text] [Related]
6. Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats. Gurkovskaya OV, Palamarchouk V, Smagin G, Goeders NE. Synapse; 2005 Sep 15; 57(4):202-12. PubMed ID: 15986362 [Abstract] [Full Text] [Related]
7. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. Psychopharmacology (Berl); 1998 May 15; 137(2):184-90. PubMed ID: 9630005 [Abstract] [Full Text] [Related]
8. Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. Goeders NE, Guerin GF. Neuropsychopharmacology; 2000 Nov 15; 23(5):577-86. PubMed ID: 11027923 [Abstract] [Full Text] [Related]
9. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. Gerrits MA, Kuzmin AV, van Ree JM. Eur Neuropsychopharmacol; 2005 May 15; 15(3):297-303. PubMed ID: 15820419 [Abstract] [Full Text] [Related]
10. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Wang J, Fang Q, Liu Z, Lu L. Psychopharmacology (Berl); 2006 Mar 15; 185(1):19-28. PubMed ID: 16374599 [Abstract] [Full Text] [Related]
11. Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats. Bäckström P, Hyytiä P. Psychopharmacology (Berl); 2003 Feb 15; 166(1):69-76. PubMed ID: 12525959 [Abstract] [Full Text] [Related]
12. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A, Kumagai T, Okubo T, Tomisawa K. J Pharmacol Exp Ther; 1999 May 15; 289(2):926-35. PubMed ID: 10215672 [Abstract] [Full Text] [Related]
13. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking. Berglind WJ, Case JM, Parker MP, Fuchs RA, See RE. Neuroscience; 2006 May 15; 137(2):699-706. PubMed ID: 16289883 [Abstract] [Full Text] [Related]
14. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Lu L, Liu D, Ceng X, Ma L. Eur J Neurosci; 2000 Dec 15; 12(12):4398-404. PubMed ID: 11122350 [Abstract] [Full Text] [Related]
15. CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats. Moffett MC, Goeders NE. Psychopharmacology (Berl); 2007 Feb 15; 190(2):171-80. PubMed ID: 17119930 [Abstract] [Full Text] [Related]
16. Antagonism of corticotropin-releasing factor CRF1 receptors blocks the enhanced response to cocaine after social stress. Ferrer-Pérez C, Reguilón MD, Manzanedo C, Aguilar MA, Miñarro J, Rodríguez-Arias M. Eur J Pharmacol; 2018 Mar 15; 823():87-95. PubMed ID: 29391155 [Abstract] [Full Text] [Related]
18. Effects of CP-154,526 on responding during extinction from cocaine self-administration in rats. Gurkovskaya O, Goeders NE. Eur J Pharmacol; 2001 Nov 30; 432(1):53-6. PubMed ID: 11734187 [Abstract] [Full Text] [Related]
19. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. Lu L, Liu Z, Huang M, Zhang Z. J Neurochem; 2003 Mar 30; 84(6):1378-86. PubMed ID: 12614338 [Abstract] [Full Text] [Related]
20. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine. Erb S, Brown ZJ. Behav Brain Res; 2006 Sep 25; 172(2):360-4. PubMed ID: 16822557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]